Novel pranoprofen‐poly(ε‐caprolactone) conjugates: microwave‐assisted synthesis and structural characterization
- 11 October 2020
- journal article
- research article
- Published by Wiley in Polymer International
- Vol. 70 (5) , 604-611
Abstract
Biodegradable polymers are used in many biomedical devices, such as implants, cellular scaffolds and drug delivery systems. To improve drug delivery capability and to reduce systemic toxicity, the interest in polymer–drug conjugates has increased remarkably. With this aim, pranoprofen (PPF) (an effective non‐steroidal anti‐inflammatory drug used mainly in ophthalmology) was conjugated to poly(ε‐caprolactone) (PCL) via microwave‐assisted transesterification, acid‐catalyzed by p ‐toluenesulfonic acid. The products obtained were characterized by NMR, matrix assisted laser desorption ionization time of flight mass spectrometry, gel permeation chromatography (which gave proof of the covalent link between PPF and PCL) and thermal analyses. The conjugates were found to contain up to 4.3% w/w of PPF and had molecular weights ranging from 5 to 12 kDa. © 2020 Society of Industrial ChemistryKeywords
Funding Information
- Consiglio Nazionale delle Ricerche
This publication has 32 references indexed in Scilit:
- Polymeric Biomaterials for Medical Implants and DevicesACS Biomaterials Science & Engineering, 2016
- Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administrationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Comparison of the Effects of Prophylactic Nonsteroidal Anti-inflammatory Drugs on Macular Edema After Cataract SurgeryJournal of the Korean Ophthalmological Society, 2010
- Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in ratsArchives of Pharmacal Research, 2009
- Biodegradable polymers as biomaterialsProgress in Polymer Science, 2007
- Topical Pranoprofen 0.1% Is As Effective Anti-Inflammatory and Analgesic Agent as Diclofenac Sodium 0.1% After Strabismus SurgeryJournal of Ocular Pharmacology and Therapeutics, 2007
- Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆Advanced Drug Delivery Reviews, 2006
- Enantiospecific disposition of pranoprofen in beagle dogs and ratsChirality, 2003
- Control of intraocular inflammation associated with cataract surgeryCurrent Opinion in Ophthalmology, 2000
- Treatment of Chronic Nonbacterial Conjunctivitis With a Cyclo-oxygenase Inhibitor or a CorticosteroidAmerican Journal of Ophthalmology, 1994